Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the response of 23 February 2026 to question 112545, what progress she has made on securing a reliable supply of testosterone and oestrogen HRT implants.

We are continuing to work closely with the Medicines and Healthcare products Regulatory Agency (MHRA) to ensure safe access to these products.

We have reached out to specialist importers in order to find alternative sources of both oestrogen and testosterone hormone replacement therapy (HRT) implants, which are not currently licensed in the United Kingdom, and it remains the case that the decision to prescribe an unlicensed imported medicine sits with the prescriber.

The MHRA is also working closely with current importers of the product and encouraging applications to supply products through the licenced medicines route.